Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-29 @ 11:45 AM
Study NCT ID:
NCT00803361
Status:
COMPLETED
Last Update Posted:
2010-12-17
First Post:
2008-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Duloxetine for the Treatment of Generalized Anxiety Disorder
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 15 week study comparing how well duloxetine and placebo treatments improve generalized anxiety disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| F1J-MC-HMFJ | OTHER | Eli Lilly and Company | View |